Holen Sie sich die Stockscreener-App
3.96
3.18%
-0.13
Schlusskurs vom Vortag:
$4.09
Offen:
$4.09
24-Stunden-Volumen:
705.55K
Relative Volume:
0.75
Marktkapitalisierung:
$69.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.54M
KGV:
-2.5548
EPS:
-1.55
Netto-Cashflow:
$-18.30M
1W Leistung:
+2.33%
1M Leistung:
-2.70%
6M Leistung:
+496.48%
1J Leistung:
+820.93%
1-Tages-Spanne:
$3.96
$4.128
1-Wochen-Bereich:
$3.80
$4.2139
52-Wochen-Spanne:
$0.34
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
Firmenname
Unicycive Therapeutics Inc
Sektor
Branche
Telefon
650-384-0642
Adresse
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Vergleichen Sie UNCY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
3.96 | 72.24M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | Guggenheim | Buy |
| 2024-04-04 | Eingeleitet | Piper Sandler | Overweight |
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
Unicycive Therapeutics Inc. recovery potential after sell offEarnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
What institutional flow reveals about Unicycive Therapeutics Inc.Trade Volume Summary & Short-Term High Return Ideas - newser.com
Market Review: Why is Unicycive Therapeutics Inc stock going downEarnings Miss & Risk Managed Investment Strategies - khodrobank.com
Class Action Lawsuit Filed Against Unicycive Therapeutics by Levi & Korsinsky Over Alleged Securities Violations - geneonline.com
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) should contact Levi & Korsinsky about pending Class ActionUNCY - PR Newswire
What’s the recovery path for long term holders of Unicycive Therapeutics Inc.Share Buyback & AI Powered Market Entry Strategies - newser.com
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky to Join Class Action Before October 14, 2025 - ACCESS Newswire
Unicycive Therapeutics, Inc. (UNCY) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
Is Unicycive Therapeutics Inc. trending in predictive chart modelsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Will Unicycive Therapeutics Inc benefit from current market trendsBreakout Watch & Weekly Sector Rotation Insights - khodrobank.com
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025UNCY - Morningstar
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Hastings Tribune
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY - GlobeNewswire Inc.
Shareholders of Unicycive Therapeutics, Inc. Should Contact - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Class Action Lawsuit Filed: Unicycive Therapeutics, Inc. (UNCY)Join by October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Agains - GuruFocus
Shareholders of Unicycive Therapeutics, Inc. Should Contact The Gross Law Firm Before October 14, 2025 to Discuss Your RightsUNCY - PR Newswire
When is the best time to exit Unicycive Therapeutics Inc.July 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Urged to Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus
Real time breakdown of Unicycive Therapeutics Inc. stock performanceEarnings Risk Report & Consistent Profit Focused Trading Strategies - newser.com
UNCY STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Visualizing Unicycive Therapeutics Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
Class Action Filed Against Unicycive Therapeutics, Inc. - GlobeNewswire
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY)October 14, 2025 Deadline to JoinContact Levi & Korsinsky - Your Wyoming Link
Short interest data insights for Unicycive Therapeutics Inc.2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Unicycive Therapeutics (NASDAQ:UNCY) Price Target Raised to $21.00 at Benchmark - MarketBeat
Unicycive Therapeutics (NASDAQ:UNCY) Stock Price Expected to Rise, Benchmark Analyst Says - Defense World
Using Ichimoku Cloud for Unicycive Therapeutics Inc. technicalsWall Street Watch & Risk Adjusted Buy/Sell Alerts - newser.com
UNCY LAWSUIT ALERT: The Gross Law Firm Notifies Unicycive - GlobeNewswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Pattern recognition hints at Unicycive Therapeutics Inc. upsideQuarterly Risk Review & Weekly Stock Breakout Alerts - newser.com
Unicycive Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Spike Watch & Accurate Intraday Trade Tips - newser.com
User - FinancialContent
Chart based exit strategy for Unicycive Therapeutics Inc.Bull Run & AI Based Buy and Sell Signals - newser.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - MarketScreener
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - MarketScreener
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics | Silicon Investor (SI) -- The First Internet Community - FinancialContent
October 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against UNCY - PR Newswire
UNCY Stockholders Have Opportunity to Lead Unicycive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Louisiana First News
Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to C - PharmiWeb.com
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Shareholders of Class Action Lawsuit and October 14, 2025 Deadline - ACCESS Newswire
Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):